![]() |
市場調査レポート
商品コード
1785208
調整用・プロセス用クロマトグラフィー市場 - 世界の産業規模、シェア、動向、機会、予測:製品別、タイプ別、最終用途別、地域別、競合別、2020年~2030年Preparative and Process Chromatography Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Type, By End-use, By Region and Competition, 2020-2030F |
||||||
カスタマイズ可能
|
調整用・プロセス用クロマトグラフィー市場 - 世界の産業規模、シェア、動向、機会、予測:製品別、タイプ別、最終用途別、地域別、競合別、2020年~2030年 |
出版日: 2025年08月06日
発行: TechSci Research
ページ情報: 英文 174 Pages
納期: 2~3営業日
|
世界の調整用・プロセス用クロマトグラフィー市場は、2024年に99億8,000万米ドルと評価され、2030年までのCAGRは8.82%で、予測期間には166億1,000万米ドルに達すると予測されています。
クロマトグラフィーは、移動相と呼ばれる流体の流れと、連続する据置型固定相の間に分散した各溶質の相対量に基づいて、混合物の成分または溶質を分離するプロセスです。調整用クロマトグラフィーの方法は、複雑な混合物の成分を分離するために使用されます。製薬分野では、分子を汚染物質から除去するために使用され、分子はその後精製され、医薬品有効成分の場合は臨床供給などさまざまな目的に使用されます。プロセス用クロマトグラフィは、化学プロセスにおける混合成分のオンライン分離と定量を可能にする分析手法です。オンラインクロマトグラフィ分析装置は、一定数のサンプルを採取し、吸着または分配カラムを用いて化学成分を分離し、検出器を用いてそれぞれの濃度を検出するという、連続的かつ自動化されたモードで機能します。
市場概要 | |
---|---|
予測期間 | 2026-2030 |
市場規模:2024年 | 99億8,000万米ドル |
市場規模:2030年 | 166億1,000万米ドル |
CAGR:2025年~2030年 | 8.82% |
急成長セグメント | プロセス用クロマトグラフィー |
最大市場 | 北米 |
バイオ医薬品需要の増加
分析法開発の複雑さ
カラム技術の進歩
Global Preparative and Process Chromatography Market was valued at USD 9.98 billion in 2024 and is expected to reach USD 16.61 billion in the forecast period with a CAGR of 8.82% through 2030. Chromatography is a process for separating constituents or solutes of a mixture based on the relative quantities of each solute dispersed between a moving fluid stream, known as the mobile phase, and a contiguous stationary phase. The method of preparative chromatography is used to separate components of complicated mixtures. In the pharmaceutical sector, it is used to clear molecules of contaminants, and the molecules are then refined and employed for a variety of purposes, such as clinical supply in the case of active medicinal components. Process chromatography is an analytical method that allows for on-line separation and quantification of mixture components in a chemical process. On-line chromatographic analyzers can function in a continuous and automated mode, taking a set number of samples, separating the chemical components using adsorption or partitioning columns, and then detecting concentration of each using a detector.
Market Overview | |
---|---|
Forecast Period | 2026-2030 |
Market Size 2024 | USD 9.98 Billion |
Market Size 2030 | USD 16.61 Billion |
CAGR 2025-2030 | 8.82% |
Fastest Growing Segment | Process Chromatography |
Largest Market | North America |
Key Market Drivers
Rising Demand for Biopharmaceuticals
The rising demand for biopharmaceuticals continues to be a major driver for the global preparative and process chromatography market. These chromatography techniques are essential for the purification and separation of complex biomolecules such as proteins, monoclonal antibodies, and gene therapies. As of 2024, biopharmaceuticals account for over 30% of all newly approved drugs by the U.S. FDA, reflecting their increasing role in modern therapeutics. Moreover, the global biologics market is expected to surpass USD 600 billion by 2030, highlighting the sustained momentum in this space.
Preparative and process chromatography techniques are critical in ensuring the high purity and quality of these biologics, especially given their structural complexity. Regulatory bodies like the U.S. FDA and EMA mandate stringent purification protocols to eliminate impurities and ensure product safety and efficacy. These techniques are particularly valuable in maintaining the structural integrity and bioactivity of sensitive biomolecules during purification. In response to industry demand, technological advancements-such as high-capacity resins, single-use systems, and continuous processing solutions-are enabling higher throughput and scalability, supporting the expanding biopharmaceutical manufacturing landscape.
The increasing prevalence of chronic and life-threatening diseases such as cancer, autoimmune disorders, and rare genetic conditions is further accelerating the demand for biopharmaceuticals, thereby driving the adoption of preparative and process chromatography. As biologics become the cornerstone of targeted therapies, manufacturers are investing heavily in advanced purification technologies to meet growing production volumes and ensure compliance with strict regulatory benchmarks. Additionally, the rise of personalized medicine and the development of cell and gene therapies are pushing the need for highly precise and scalable chromatography solutions capable of handling complex purification challenges associated with individualized treatments.
Key Market Challenges
The complexity of Method Development
Developing effective chromatography methods involves optimization of various parameters, such as column selection, mobile phase composition, flow rates, and detection conditions. This process can be time-consuming and resource-intensive, requiring significant investments in expertise, equipment, and consumables. The complexity and length of method development can discourage organizations from adopting chromatography techniques. Successful method development demands a deep understanding of the principles of chromatography, separation science, and the specific requirements of the target compounds. Organizations may face challenges in finding and retaining personnel with the necessary expertise, especially if the technology is continuously evolving. Method development often involves a trial-and-error approach to find the optimal conditions for separation and purification. This iterative process can lead to increased consumable usage, longer development timelines, and higher costs, which may deter some organizations from adopting chromatography methods. The complexity of samples, such as those from biological sources or intricate mixtures, can make method development even more challenging. Customizing methods to effectively separate and purify complex samples requires specialized knowledge and careful experimentation.
Key Market Trends
Advancements in Column Technologies
New column packing materials, stationary phases, and geometries are designed to provide higher separation efficiencies. This leads to better resolution, shorter analysis times, and increased productivity in both analytical and preparative chromatography applications. Advancements in column chemistry allow for the development of columns with enhanced selectivity for specific compounds or classes of molecules. This is especially beneficial in complex samples where targeted separation is critical. Columns designed for high-throughput applications enable rapid analysis and purification, reducing analysis times and increasing sample throughput. This is particularly important for industries with high sample volumes, such as pharmaceuticals and biotechnology. New column designs and materials facilitate seamless scale-up from laboratory to pilot and production scales. This scalability is crucial for process chromatography in industries like biopharmaceuticals, where large-scale purification is required. Advances in chiral column technology enable the separation of enantiomers, which are mirror-image molecules with different biological activities. This is essential for drug discovery and development, as well as industries where chirality plays a crucial role. Monolith columns offer unique advantages such as high flow rates, reduced backpressure, and efficient mass transfer. These columns are increasingly being used in applications where traditional packed-bed columns may be limiting.
In this report, the Global Preparative and Process Chromatography Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Preparative and Process Chromatography Market.
Global Preparative and Process Chromatography market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: